Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Treg cell IL-10 and IL-35 exhaust CD8+ T cells in tumors.

Damo M, Joshi NS.

Nat Immunol. 2019 Jun;20(6):674-675. doi: 10.1038/s41590-019-0389-y. No abstract available.

PMID:
31011189
2.

Improving Efficacy and Safety of Agonistic Anti-CD40 Antibody Through Extracellular Matrix Affinity.

Ishihara J, Ishihara A, Potin L, Hosseinchi P, Fukunaga K, Damo M, Gajewski TF, Swartz MA, Hubbell JA.

Mol Cancer Ther. 2018 Nov;17(11):2399-2411. doi: 10.1158/1535-7163.MCT-18-0091. Epub 2018 Aug 10.

PMID:
30097487
3.

TLR-3 stimulation improves anti-tumor immunity elicited by dendritic cell exosome-based vaccines in a murine model of melanoma.

Damo M, Wilson DS, Simeoni E, Hubbell JA.

Sci Rep. 2015 Dec 3;5:17622. doi: 10.1038/srep17622.

4.

Site-specific integration and tailoring of cassette design for sustainable gene transfer.

Lombardo A, Cesana D, Genovese P, Di Stefano B, Provasi E, Colombo DF, Neri M, Magnani Z, Cantore A, Lo Riso P, Damo M, Pello OM, Holmes MC, Gregory PD, Gritti A, Broccoli V, Bonini C, Naldini L.

Nat Methods. 2011 Aug 21;8(10):861-9. doi: 10.1038/nmeth.1674.

PMID:
21857672
5.

Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk.

Mátrai J, Cantore A, Bartholomae CC, Annoni A, Wang W, Acosta-Sanchez A, Samara-Kuko E, De Waele L, Ma L, Genovese P, Damo M, Arens A, Goudy K, Nichols TC, von Kalle C, L Chuah MK, Roncarolo MG, Schmidt M, Vandendriessche T, Naldini L.

Hepatology. 2011 May;53(5):1696-707. doi: 10.1002/hep.24230.

Supplemental Content

Support Center